Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent. T he global syphilis testing market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America, Middle East & Africa (LAMEA) m
A sector as vibrant as Life Sciences requires a dedicated team to keep pace with continuous changes in dynamics. At Allied Market Research, we offer experts’ opinion and proficiency to move into new zones of the business. Here, the life sciences sector covers diverse portfolios, such as restorative gadgets, and more extensive issues such as pharmaceutical outsourcing and method, and specialty parts, including drug convenience. In addition, it comprehends key patterns and developments in this sec